Rubin Marc

CIK 00014123775 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001412377

Recent Transactions

50 trades

Conversion
CURIS INC$CRIS
Series B Convertible Preferred Stock
2026-03-20−20→ 0 total
Conversion
CURIS INC$CRIS
Common Stock
2026-03-20+26,667→ 28,108 total
Award
CURIS INC$CRIS
Series C Warrant (right to buy)
2026-03-17+26,667→ 26,667 total
Award
CURIS INC$CRIS
Series B Convertible Preferred Stock
2026-03-17+20→ 20 total
Award
CURIS INC$CRIS
Series A Warrant (right to buy)
2026-03-17+26,667→ 26,667 total
Award
CURIS INC$CRIS
Series B Warrant (right to buy)
2026-03-17+26,667→ 26,667 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2025-05-20$3.13/sh+14,400→ 14,400 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2025-01-28$3.13/sh+1,600→ 1,600 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-01-23+60,000→ 60,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2024-05-21$11.62/sh+4,250→ 4,250 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2024-01-24+50,000→ 50,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2023-01-26+40,000→ 40,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2023-01-23+85,000→ 85,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2022-01-31+85,000→ 85,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2022-01-24+40,000→ 40,000 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Option to Purchase Common Stock
2022-01-05+65,000→ 65,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+70,000→ 70,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+40,000→ 40,000 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Option to Purchase Common Stock
2021-02-10+150,000→ 150,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2021-01-28+33,000→ 33,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2020-03-02+180,000→ 180,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2020-01-09+30,000→ 30,000 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Option to Purchase Common Stock
2019-04-02+200,000→ 200,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2019-02-22−859→ 33,065 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-02-22$6.02/sh−859→ 13,581 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-02-22$2.39/sh+859→ 14,440 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-02-21$6.00/sh−7,000→ 13,581 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-02-21$2.39/sh+43,326→ 56,907 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-02-21$6.02/sh−43,326→ 13,581 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2019-02-21−43,326→ 33,924 total
Sale
CURIS INC$CRIS
Common Stock
2019-01-23$1.05/sh−18,500→ 28,819 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2019-01-21+180,000→ 180,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2019-01-16+25,000→ 25,000 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock
2018-09-21$0.25/sh+400,000→ 556,317 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Warrants
2018-09-21+400,000→ 400,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-09-04$6.58/sh−11,900→ 20,581 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-09-04−6,000→ 16,500 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-09-04+6,000→ 32,481 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-08-30−29,000→ 22,500 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-08-30+29,000→ 84,581 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-08-30$6.08/sh−58,100→ 26,481 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Option to Purchase Common Stock
2018-03-07+170,000→ 170,000 total
Award
CURIS INC$CRIS
Common stock
2018-01-22+185,000→ 236,596 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2017-12-14+77,250→ 77,250 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2017-12-08$1.85/sh+7,000→ 55,581 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2017-12-08$1.85/sh+7,000→ 55,581 total
Purchase
CURIS INC$CRIS
Common Stock
2017-11-16$0.98/sh+25,000→ 51,596 total
Award
CURIS INC$CRIS
Non-qualified stock option
2017-02-28+120,000→ 120,000 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Option to Purchase Common Stock
2017-02-13+70,000→ 70,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2016-12-15+51,500→ 51,500 total

Rubin Marc

Recent Transactions

Companies

Recent Filings

Address